Wednesday, 16 August 2017

Korea News

  • Korean megacorp to export HIS to Saudi

    Korea |  News | By BioSpectrum Bureau | 0 Comment | 11 Jul, 2014

    Singapore: A Korean consortium of healthcare firms have successfully inked a $69.1 million worth deal, with the Saudi Arabia's Ministry of National Guard (MNG) to provide a medical informat...Read more

  • Alvogen acquires Korea's Dream Pharma

    Korea |  News | By BioSpectrum Bureau | 0 Comment | 08 Aug, 2014

    Singapore: The birth of one of the largest generic pharmaceutical companies in South Korea just came about when Alvogen decided to acquire Korea's Dream Pharma. The deal, closed in cash, in...Read more

  • Globalization, demography drive APAC healthcare industry

    Korea |  Analysis | By BioSpectrum Bureau | 0 Comment | 27 Jul, 2012

    Singapore: The healthcare industry in Asia Pacific (APAC) is rapidly growing, fuelled by increased spending on health, liberalization of investment policies, growing medical tourism activit...Read more

  • Planmed 3D CT imager gets Korean FDA nod

    Korea |  Regulatory | By BioSpectrum Bureau | 0 Comment | 22 Feb, 2013

    Singapore: Planmed, which is represented in Korea by Dong Kang Medical Systems, received clearance for its Verity Extremity Scanner from the Korean Food and Drug Administration (KFDA). It i...Read more

  • Singapore, Korea scientists find clue to tumour suppression mechanism

    Korea |  News | By BioSpectrum Bureau | 0 Comment | 12 Nov, 2013

    Singapore: RUNX3, a gene that is intensively studied for its function as a tumour suppressor, is likely to be a key and critical component of the body's first line of defence against lung c...Read more

  • Samsung to make BMS cancer antibody drug in Korea

    Korea |  News | By BioSpectrum Bureau | 0 Comment | 30 Jul, 2013

    Singapore: Bristol-Myers Squibb (BMS) and Samsung BioLogics entered into a 10-year agreement under which Samsung BioLogics will manufacture a commercial antibody cancer drug for Bristol-Mye...Read more

  • FDA nod for Samsung's new radiography system

    Korea |  News | By BioSpectrum Bureau | 0 Comment | 07 Aug, 2015

    Singapore: NeuroLogica, a subsidiary of Samsung Electronics has announced that the Samsung GC85A Digital Radiography (DR) system has received 510(k) FDA clearance, paving the way for its av...Read more

  • US firm files antibody patent in Japan, Korea

    Korea |  News | By BioSpectrum Bureau | 0 Comment | 27 Aug, 2013

    Singapore: MMRGlobal received confirmation of the filings of a divisional application for its antibody technology in Japan and South Korea as a result of expedited patent allowance Program,...Read more

  • F&S: S. Korea will be biosimilars leader by 2020

    Korea |  Analysis | By BioSpectrum Bureau | 0 Comment | 08 Jan, 2013

    ‎Singapore: Since South Korea introduced a regulatory pathway for manufacturing biologics in 2009, the government has raised its stakes in the biosimilars market. It is providing both...Read more

  • Is a new therapy for diabetes on the way?

    Korea |  News | By BioSpectrum Bureau | 0 Comment | 09 Sep, 2014

    Singapore: In a breakthrough discovery, Korean scientists have identified that regulating the effect of a protein related to the detoxification function of the liver, can improve diabetes. ...Read more

  • 3SBio to develop antibody for acute leukemia

    Korea |  News | By BioSpectrum Bureau | 0 Comment | 08 Aug, 2014

    Singapore: Chinese biotechnology firm, 3SBio, has signed an exclusive license with Korean firm, DiNonA  for the development, manufacturing and marketing of Leukotuximab. It is an anti JL-1...Read more

  • Taiho terminates oranitib Ph III trial

    Korea |  News | By BioSpectrum Bureau | 0 Comment | 05 Aug, 2014

    Singapore: Faced with disappointing results, Japan's large drugmaker, Taiho Pharmaceutical has said that it is terminating a Phase III clinical trial of the angiogenesis inhibitor TSU-68 (o...Read more

  • Japanese, Korean firm to jointly develop breast cancer drug

    Korea |  News | By BioSpectrum Bureau | 0 Comment | 08 Jan, 2015

    Singapore: Japanese company, Kyowa Hakko Kirin and Korean firm, Syndax Pharmaceuticals, have entered into a license agreement for the exclusive rights to develop and commercialize entinosta...Read more

  • Korean doctors skeptical about Telemedicine

    Korea |  News | By BioSpectrum Bureau | 0 Comment | 24 Sep, 2014

    Singapore: Korean doctors have expressed concern over the controversial telemedicine bill that is expected to be effective by next year. Doctors opine that they will no longer be able to pr...Read more

  • Swedish firm partners with Sanofi to expand in Asia

    Korea |  News | By BioSpectrum Bureau | 0 Comment | 27 May, 2015

    Singapore: Sweden-based company NeuroVive Pharmaceutical's Asia arm has signed a collaboration agreement with Sanofi's affiliate for the development and commercialization of CicloMulsion in...Read more

  • Korea, Ontario Centers collaborate on tech research

    Korea |  News | By BioSpectrum Bureau | 0 Comment | 23 Sep, 2014

    Singapore: The Korea Evaluation Institute of Industrial Technology (KEIT) has inked a Memorandum of Understanding with the Ontario Centers of Excellence (OCE), to collaborate and develop te...Read more

  • Korea close to discovering HIV cure

    Korea |  News | By BioSpectrum Bureau | 0 Comment | 05 Aug, 2014

    Singapore: Scientists have finally discovered an enzyme that could curb the increasing menace of HIV and promise a possible cure in the future. A group of Korean medical researchers have di...Read more

  • Y brain Korea receives $3.5mn Series A funding

    Korea |  News | By BioSpectrum Bureau | 0 Comment | 28 Aug, 2014

    Singapore: Korea-based healthcare wearables start-up firm, Y brain, has raised $3.5 million in Series A funding for its novel wearable device that can treat neurological disorders. Y brain...Read more

Survey Box

Does Asia have more to offer to the global 3D cell culture market?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls